| To: Anthony@Pacific who started this subject | 6/17/2002 10:54:03 AM | | From: SiouxPal | of 116402 | | | Wonder how WSJ missed the fact that Martha Stewarts stock broker used to work for Imclone? PETER E BACANOVIC also has disclosure and I have requested a copy of his CRD.
File for: Data Current as of: 06/17/2002
CRD# 2416631
PETER E BACANOVIC
PREVIOUS EMPLOYMENT
This section provides 10 years of an individual's employment history. If the individual is currently registered with the NASD, employment history will be displayed for the previous 10 years. If the individual is not currently registered with the NASD, employment history will be displayed for the 10 years prior to termination of the registration. For employers that are or were an NASD member firm, the firm's CRD number, the location of the office where the broker was employed, and the dates of employment will be displayed.
Employing Firm: #IA MERRILL LYNCH, PIERCE, FENNER & SMIT
Firm CRD Number:
Office of Employment
Address: NEW YORK, NY
Start Date: 10/1993
End Date: 12/1997
Employing Firm: AMERICAN PEGASUS INC.
Firm CRD Number:
Office of Employment
Address: NEW YORK, NY
Start Date: 08/1992
End Date: 09/1993
Employing Firm: IMCLONE SYSTEMS INC.
Firm CRD Number:
Office of Employment
Address: NEW YORK, NY
Start Date: 06/1990
End Date: 07/1992
Stewart, broker differ on timing of ImClone sale-WSJ
NEW YORK, June 17 (Reuters) - Martha Stewart and her broker differ on the timing of the order to sell her ImClone <IMCL.O> shares, which could potentially be significant to a probe on whether she had inside information regarding the biotechnology firm, the Wall Street Journal reported on Monday..
A person familiar with the events told the Journal that Martha Stewart's broker -- Merrill Lynch's <MER.N> Peter Bacanovic -- said they agreed in mid-December, not late November, to consider selling her ImClone stock if the price fell below $60 a share.
The broker's recollection, which the source said was supported by notes he took of the meeting, differs from Stewart's who has publicly said and told congressional investigators that the agreement was struck in late November.
Martha Stewart could not be immediately reached for comment.
Stewart, chief executive of Martha Stewart Living Omnimedia Inc. <MSO.N>, sold shares of ImClone Systems Inc. in December just the day before the drugmaker's cancer drug Erbitux was rejected by the Food and Drug Administration.
Stewart is a former girlfriend of ImClone's ex-chief executive, Sam Waksal. Last week he was taken from his New York home by FBI agents and charged with conspiracy, securities fraud and perjury.
According to the report, Bacanovic is a friend of Waksal and is also the broker for Waksal's daughter, Aliza, who investigators say sold ImClone shares after being tipped by her father about the FDA rejection.
06/17/02 04:44 ET
Copyright 2002 Reuters Limited. |
| | Anthony @ Equity Investigations, Dear Anthony, | Stock Discussion ForumsShare | Recommend | Keep | Reply | Mark as Last Read |
|
